Please assess the completion status of the following clinical trial:

Trial Title: Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female 6 months to 17 years 11 months of age, inclusive;~* Female subjects of childbearing potential must use adequate contraception~* Diagnosed with CDAD~Exclusion Criteria:~* Concurrent use of oral vancomycin or metronidazole or any other effective treatments for CDAD~* Fulminant colitis~* History of inflammatory bowel disease~* Pregnant or breast-feeding~* Need for concurrent use of some P-glycoprotein inhibitors during therapy

- Gender: ALL
- Minimum Age: 6 Months
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- fidaxomicin (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).